Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells

Stem Cells

Volumn 24, Issue 2, 2006, Pages 462-471

  Sotiropoulou, Panagiota A ^a   Perez, Sonia A ^a   Salagianni, Maria ^a   Baxevanis, Constantin N ^a   Papamichail, Michael ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Clinical trials; Culture conditions; Expansion; Mesenchymal stem cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLUCOSE; GLUTAMINE; HLA ANTIGEN CLASS 1; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LARGE SCALE PRODUCTION; MALE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; T LYMPHOCYTE; UPREGULATION; CELL PROLIFERATION; CELL SEPARATION; CULTURE MEDIUM; CULTURE TECHNIQUE; METHODOLOGY; PHYSIOLOGY; STEM CELL;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; CULTURE MEDIA; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STEM CELLS; STEM CELLS;

EID: 33745266607     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0331     Document Type: Article

References (51)

1. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001;226:507-520.
2. Barry L, Murphy JM. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 2004;36:568-584.
3. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
4. Devine SM, Cobbs C, Jennings M et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999-3001.
5. Chapel A, Bertho JM, Bensidhoum M et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003;5:1028-1038.
6. Zhao RC, Liao L, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med 2004;143:284-291.
7. Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316.
8. Horwitz EM, Gordon PL, Koo WKK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002;99:8932-8937.
9. Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002;30:215-222.
10. Mazzini L, Fagioli F, Boccaletti R et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:158-161.
11. Chen S-L, Fang W-W, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
12. Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76:1208-1213.
13. Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-896.
14. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003;5:485-489.
15. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
16. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naïve and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-3729.
17. Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621.
18. Zhang W, Ge W, Li C et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004;13:263-271.
19. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
20. Ikehara S. New strategies for BMT, organ transplantation, and regeneration therapy. Hematology (Am Soc Hematol Educ Program) 2003;8:77-81.
21. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
22. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res 2002;62:3603-3608.
23. Stagg J, Lejeune L, Paquin A et al. Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy. Hum Gene Ther 2004;15:597-608.
24. Nakamura K, Ito Y, Kawano Y et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004;11:1155-1164.
25. Colter DC, Class R, DiGirolamo CM et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000;97:3213-3218.
26. Sekiya I, Larson BL, Smith JR et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. STEM CELLS 2002;20:530-541.
27. Caterson EJ, Nesti LJ, Danielson KG et al. Human marrow-derived mesenchymal progenitor cells: Isolation culture, expansion and analysis of differentiation. Mol Biotechnol 2002;20:245-256.
28. Reyes M, Lund T, Aguiar D et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
29. Hung S-C, Chen N-J, Hsieh S-L et al. Isolation and characterization of size-sieved stem cells from human bone marrow. STEM CELLS 2002;20:249-258.
30. Smith JR, Pochampally R, Perry A et al. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. STEM CELLS 2004;22:823-831.
31. van den Bos C, Mosca JD, Winkles J et al. Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell 1997;10:45-50.
32. Tsutsumi S, Shimazu A, Miyazaki K et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419.
33. Hori Y, Inoue S, Hirani Y et al. Effect of culture substrates and fibroblast growth factor addition on the proliferation and differentiation of rat bone marrow stromal cells. Tissue Eng 2004;10:995-1005.
34. Solchaga LA, Penick K, Porter JD et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005;203:398-409.
35. Kotobuki N, Hirose M, Takakura Y et al. Cultured autologous human cells for hard tissue regeneration: Preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004;28:33-39.
36. DiGirolamo CM, Stokes D, Colter D et al. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with greatest potential to propagate and differentiate. Br J Haematol 1999;107:275-281.
37. Reyes M, Verfaillie CM. Turning marrow into brain: Generation of glial and neuronal cells from adult bone marrow mesenchymal stem cells. Blood 1999;94(suppl 1):377a.
38. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001;98:7841-7845.
39. Jaiswal N, Haynesworth SE, Caplan AI et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
40. Maitra B, Szekely E, Gjini K et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004;33:597-604.
41. Kuznetsov SA, Krebsbach PH, Satomura K et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;12:1335-1347.
42. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-3844.
43. Chen BJ, Morris RE, Chao NJ. Graft-versus-host disease prevention by rapamycin: Cellular mechanisms. Biol Blood Marrow Transplant 2000;6:529-536.
44. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 2001;3:393-396.
45. Bianchi G, Banfi A, Mastrogiacomo M et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105.
46. Martin I, Muraglia A, Campanile G et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997;138:4456-4462.
47. Nagai H, Tsukuda R, Yamasaki H et al. Systemic injection of FGF-2 stimulates endocortical bone modelling in SAMP6, a murine model of low turnover osteopenia. J Vet Med Sci 1999;61:869-875.
48. Christie A, Butler M. Growth and metabolism of a murine hybridoma in cultures containing glutamine-based dipeptides. Focus 1994;16:9-13.
49. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
50. Sigmond RS, Goldman M. Corona discharge physics and applications. Nato Adv Study Inst Ser B 1978;89:1-64.
51. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion to signaling regulators. Nat Rev Mol Cell Biol 2003;4:33-45.